Jia-rung Tsai
No. 1650 Taiwan Boulevard Sect. 4
Taitung, TNQ 40705, Taiwan
Taitung, TNQ 40705, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Doxorubicin-mediated retardation of aggresome formation enhances Carfilzomib-induced cell death synergistically by augmenting ER stress and proapoptotic signaling.
Journal: European journal of pharmacology
Published: May 13, 2025
Alisertib inhibits acute myeloid leukemia cell growth by inhibiting STAT3 activation.
Journal: Toxicology and applied pharmacology
Published: March 12, 2025
Doxorubicin synergizes bortezomib-induced multiple myeloma cell death by inhibiting aggresome formation and augmenting endoplasmic reticulum/Golgi stress and apoptosis.
Journal: Journal of translational medicine
Published: September 14, 2024
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach.
Journal: Clinical proteomics
Published: May 23, 2024
Myeloperoxidase and Thyrotropin-Releasing Hormone Within Leukaemia Stem Cells Increased Chemosensitivity in Acute Myeloid Leukaemia.
Journal: Journal of cellular and molecular medicine
Published: November 07, 2023
Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: June 28, 2023
The crescent-like Golgi ribbon is shaped by the Ajuba/PRMT5/Aurora-A complex-modified HURP.
Journal: Cell communication and signaling : CCS
Published: March 14, 2023
Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
Journal: Hematological oncology
Published: October 31, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026